Identification of the initial binding sites of αs2-casein f(183-207) and effect on bacterial membranes and cell morphology

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 10, 2008, Pages 2444-2449

  López Expósito, Iván ^a   Amigo, Lourdes ^a   Recio, Isidra ^a  

^a INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

Author keywords

s2 casein; Antimicrobial peptides; Binding sites; Milk derived bioactive peptides; Permeabilization

Indexed keywords

ALPHA S2 CASEIN F[183-207]; BACTERIUM LIPOPOLYSACCHARIDE; CASEIN; LACTOFERRICIN; LIPOTEICHOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; CELL STRUCTURE; DRUG BINDING SITE; DRUG EFFECT; DRUG PROTEIN BINDING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BINDING SITES; CASEINS; CATTLE; CELL MEMBRANE; CELL SHAPE; ESCHERICHIA COLI; LIPOPOLYSACCHARIDES; PEPTIDE FRAGMENTS; STAPHYLOCOCCUS; TEICHOIC ACIDS;

BACTERIA (MICROORGANISMS); BOVINAE; NEGIBACTERIA; POSIBACTERIA;

EID: 52049095275     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.06.018     Document Type: Article

References (35)

1. van't Hof W., Veernan E.C.I., Helmerhorst E.J., and Amerongen A.V.N. Antimicrobial peptides: properties and applications. Biol. Chem. 382 (2001) 597-619
2. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462 (1999) 55-70
3. Kragol G., Lovas S., Varadi G., Condie B.A., Hoffmann Jr. R., and Otvos L. The antibacterial peptide pyrrocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40 (2001) 3016-3026
4. Ulvatne H., Samuelsen Ø., Haukland H.H., Krämer M., and Vorland L.H. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol. Lett. 237 (2004) 377-384
5. Couto M.A., Harwing S.S., and Lehrer R.I. Selective inhibition on microbial by ENAP-2, an antimicrobial peptide from equine neutrophils. Infect. Immun. 61 (1993) 2991-2994
6. Pakkanen R., and Aalto J. Growth factors and antimicrobial factors of bovine colostrums. Int. Dairy J. 7 (1997) 285-297
7. Pellegrini A. Antimicrobial peptides from food proteins. Curr. Pharm. Des. 9 (2003) 1225-1238
8. López-Expósito I., and Recio I. Protective effect of milk peptides: antibacterial and antitumor properties. Adv. Exp. Med. Biol. 606 (2008) 271-293
9. López-Expósito I., and Recio I. Antibacterial activity of peptides and folding variants from milk proteins. Int. Dairy J. 16 (2006) 1294-1305
10. Bellamy W., Takase M., Wakabayahi H., Kawase K., and Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73 (1992) 472-479
11. Jones E.M., Smart A., Bloomberg G., Burgess L., and Millar M.R. Lactoferricin, a new antimicrobial peptide. J. Appl. Bacteriol. 77 (1994) 208-214
12. Muñoz A., and Marcos J.F. Activity and mode of action against fungal phytopathogens of bovine lactoferrin-derived peptides. J. Appl. Microbiol. 101 (2006) 1199-1207
13. León-Sicarios N., Reyes-López M., Ordaz-Pichardo C., and de la Garza M. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronizadole in Entoamoeba histolytica. Biochem. Cell. Biol. 84 (2006) 327-336
14. Piertrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., and Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection. Antivir. Res. 69 (2006) 98-106
15. Iigo M., Kuhara T., Ushida Y., Sekine K., Moore M.A., and Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis 17 (1999) 35-40
16. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta, Biomembr. 1778 (2008) 357-375
17. Levay P.F., and Viljoen M. Lactoferrin, a general review. Haematologica 80 (1995) 252-267
18. Bellamy W., Wakabayashi H., Takase M., Kawase K., Shimamura S., and Tomita M. Killing of Candida albicans by lactoferricin-B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 182 (1993) 97-105
19. Vorland L.H., Ulvatne H., Rekdal Ø., and Svendsen J.S. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand. J. Infect. Dis. 31 (1999) 467-473
20. Haukland H.H., Ulvatne H., Sandvik K., and Vorland L.H. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett. 508 (2001) 389-393
21. s2-casein. Biochim. Biophys. Acta 1428 (1999) 314-326
22. López-Expósito I., Pellegrini A., Amigo L., and Recio I. Synergistic effect between different milk-derived peptides and proteins. J. Dairy Sci. 91 (2008) 2184-2189
23. Lehrer R.I., Barton A., and Ganz T. Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J. Immunol. Methods 108 (1988) 153-158
24. s2-casein. Int. Dairy J. 16 (2006) 1072-1080
25. Recio I., and Visser S. Two ion-exchange chromatographic methods for the isolation of antibacterial peptides from lactoferrin. In situ enzymatic hydrolysis on an ion-exchange membrane. J. Chromatogr. A. 831 (1999) 191-201
26. Angus B.L., Carey A.M., Caron D.A., Kropinski A.M.B., and Hancock R.E.W. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob. Agents Chemother. 21 (1982) 299-309
27. Eriksson M., Nielsen P.E., and Good L. Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J. Biol. Chem. 277 (2002) 7144-7147
28. Chapple D.S., Mason D.J., Joannou C.L., Odell E.W., Gant V., and Evans R.W. Structure-function relationship of antibacterial peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect. Immun. 66 (1998) 2434-2440
29. Ulvatne H., Haukland H.H., Olsvik Ø., and Vorland L.H. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett. 492 (2001) 62-65
30. Niidome T., Kobayashi K., Arakawa H., Hatakeyama T., and Aoyagi H. Structure-activity relationship of an antibacterial peptide, Maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. J. Peptide Sci. 10 (2004) 414-422
31. Hancock R.E.W., and Chapple S. Peptide antibiotics. Antimicrob. Agents Chemother. 43 (1999) 1317-1323
32. Chan S.C., Yau W.L., Wang W., Smith D.K., Sheu F.S., and Chen H.M. Microscopic observations of the different morphological changes caused by antibacterial peptide on Klebsiella pneumoniae and HL-60 leukemia cells. J. Peptide Sci. 4 (1998) 413-425
33. Yamauchi K., Tomita M., Giehl T.J., and Ellison III R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin fragment. Infect. Immun. 61 (1993) 719-728
34. Vogel H.J., Schibli D.J., Weiguo J., Lohmeier-Vogel E.M., Epand R.F., and Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan and arginine containing peptides. Biochem. Cell Biol. 80 (2002) 49-63
35. Farnaud S., Spiller C., Moriarty L.C., Patel A., Gant V., Odell E.W., and Evans R.W. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiol. Lett. 233 (2004) 193-199